92
69
Growth Score
-1 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
SR One is the corporate venture capital arm of GlaxoSmithKline.
Jens Eckstein: PresidentPast Role: TVM Capital, Venture Partner and Entrepreneur-in-Residence
Matthew Foy: PartnerPast Role: Greenhill & Co, Vice President - M&A Banker
GlaxoSmithKline
About the Company
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly
impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
